Q11151 (Q11151): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
9,107,700.0 Czech koruna
| |||||||||||||||
| Property / EU contribution: 9,107,700.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
364,308.0 Euro
| |||||||||||||||
| Property / EU contribution: 364,308.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 364,308.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 364,308.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
13,011,000.0 Czech koruna
| |||||||||||||||
| Property / budget: 13,011,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
520,440.0 Euro
| |||||||||||||||
| Property / budget: 520,440.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 520,440.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 520,440.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 00:09, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
9,107,700.0 Czech koruna
0 references
13,011,000.0 Czech koruna
0 references
70 percent
0 references
19 January 2017
0 references
31 August 2019
0 references
MedChemBio
0 references
49°35'41.89"N, 17°16'31.12"E
0 references
77900
0 references
1.podprojekt pomůže ve fázi výroby hodnocených léčiv. přípravků pro moderní terapie(LPMT). Cílem je zajistit kvalitní výsledky pre-validačních a valid. studií, a vyvinout specif. metody kontroly kvality nových produktů pro dokončení vývoje a zahájení výroby LPMT v režimu SVP. Součástí bude i zahájení studie směřující k identifikaci biomarkerů účinnosti LPMT. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_079/0008825
0 references